FOXD3 and thyroid cancer: Hazard ratio analysis indicated that elevated F10 (HR = 1.006, p < 0.002), FOXD3 (HR = 1.14, p < 0.001), and SLC12A5 (HR = 1.003, p < 0.05) expression in patients with thyroid cancer was closely associated with poorer prognoses.